GlassScriptPhysician profile
Craig Michael Forleiter
NPI 1700178936
$20,797.26
in general payments reported to CMS, 2019-2025
22 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $800 · 2021: $1,550 · 2022: $1,244 · 2023: $1,086 · 2024: $1,996 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Food and Beverage: $2,838 · Long Term Medical Supply Or Device Loan: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $13,500.00 |
| Food and Beverage | $2,837.57 |
| Long Term Medical Supply Or Device Loan | $537.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bimini Technologies LLC | $13,000.00 | 2025 | |
| Sientra, INC. | $1,660.63 | 2021-2022 | |
| Allergan, INC. | $1,479.33 | 2019-2022 | |
| Integra Lifesciences Corporation | $950.73 | 2022-2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Abbvie INC. | $923.10 | 2023-2025 | |
| Elucent Medical | $671.85 | 2024 | |
| Tela Bio, INC. | $506.72 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Musculoskeletal Transplant Foundation INC. | $354.74 | 2020-2024 | |
| Dilon Technologies, INC. | $263.60 | 2023-2024 | Hemoblast Bellows |
| Axogen | $259.19 | 2022-2025 | Avance Nerve Graft |
| Endo Pharmaceuticals INC. | $131.24 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 | |
| Smith+Nephew, INC. | $98.01 | 2021-2024 | Collagenase Santyl, Grafix, Stravix |
| Merz North America, INC. | $91.33 | 2022 | |
| Galderma Laboratories, L.P. | $83.84 | 2021-2024 | Dysport |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $61.32 | 2023-2025 | |
| Polynovo North America LLC | $43.92 | 2025 | Novosorb Btm |
| Kerecis Limited | $35.03 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Davol INC. | $28.79 | 2022 | |
| Ethicon US, LLC | $20.21 | 2025 | Vistaseal, Ethicon, Stratafix |
| Bard Peripheral Vascular, INC. | $17.51 | 2021 | |
| Lilly USA, LLC | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Forleiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.